Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients

Catheterization and Cardiovascular Interventions

Volumn 57, Issue 4, 2002, Pages 486-495

  Eggebrecht, Holger ^a   Haude, Michael ^a   Woertgen, Uta ^a   Schmermund, Axel ^a   Von Birgelen, Clemens ^a   Naber, Christoph ^a   Baumgart, Dietrich ^a   Kaiser, Christoph ^a   Oldenburg, Olaf ^a   Bartel, Thomas ^a   Kroeger, Knut ^a   Erbel, Raimund ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Angio Seal; Bleeding; Catheterization; Closure device; Femoral; Vascular access complications

Indexed keywords

COLLAGEN;

ADULT; AGED; ARTICLE; BLEEDING; COMPRESSION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DEATH; DEVICE; FEMALE; GENDER; HEART CATHETERIZATION; HEMOSTASIS; HUMAN; IMMOBILIZATION; INFECTION; MAJOR CLINICAL STUDY; MALE; PULSE RATE; RETROPERITONEAL HEMATOMA; THROMBOSIS; TRANSFUSION; VASCULAR ACCESS; VASCULAR CLOSURE DEVICE; VASCULAR SURGERY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COLLAGEN; CORONARY ARTERIOSCLEROSIS; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HEMOSTATIC TECHNIQUES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0036897266     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10254     Document Type: Article

References (46)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
2. Erbel R, Haude M, Hopp HW, Franzen D, Rupprecht HJ, Heublein B, Fischer K, de Jaegere P, Serruys P, Rutsch W, Probst P. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty: Restenosis Stent Study Group. N Engl J Med 1998;339:1672-1678.
3. EPIC investigators. Use of a monoclonal antibody directed against glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
4. Dick RJ, Popma JJ, Muller DW, Burek KA, Topol EJ. In-hospital costs associated with new interventional devices. Am J Cardiol 1991;68:879-885.
5. Sanborn TA, Gibbs HH, Brinker JA, Knopf WA, Kosinski EJ, Roubin GS. A multicenter randomised trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993;22:1273-1279.
6. Kussmaul WG III, Buchbinder M, Whitlow PL, Aker UT, Heuser RR, King SB, Kent KM, Leon MB, Kolansky DM, Sandza JG Jr. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: Results of a randomised trial of a novel hemostatic device. J Am Coll Cardiol 1995;25:1685-1692.
7. Mooney MR, Ellis SG, Gershony G, Yehyawi KJ, Kummer B, Lowrie M. Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: Initial U.S. feasibility trial using the Duett vascular closure device. Cathet Cardiovasc Intervent 2000;50:96-102.
8. Carere RG, Webb JG, Buller CEH, Wilson M, Rahman, Spinelli J, Anis AH. Suture closure of femoral arterial sites after coronary angioplasty followed by same-day discharge. Am Heart J 2000;139:52-58.
9. Silber S. Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: Analysis of 6007 published cases. Am Heart J 1998;135:152-156.
10. De Swart H, Dijkman L, Hofstra L, Bär FW, Van Ommen V, Tordoir J, Wellens HJJ. A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites. Am J Cardiol 1993;72:445-449.
11. Aker UT, Kensey KR, Heuser RR, Sandza JG, Kussmaul WG III. Immediate arterial hemostasis after cardiac catheterization: Initial experience with a new puncture closure device. Cathet Cardiovasc Diagn 1994;31:228-232.
12. Ward SR, Casale P, Raymond R, Kussmaul WG III, Simpfendorfer C, for the Angio-Seal Investigators. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Am J Cardiol 1998;81:569-572.
13. Warren BS, Warren SG, Miller SD. Predictors of complications and learning curve using the Angio-Seal closure device following interventional and diagnostic catheterization. Cathet Cardiovasc Intervent 1999;48:162-166.
14. Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, Cutlip DE, Fitzpatrick M, Ho KKL, Kuntz RE. Suture-mediated closure of the femoral access site after cardiac catheterization: Results of the suture to ambulate and discharge (STAND I and STAND II) trials. Am J Cardiol 2000;85:864-869.
15. Silber S, Dörr R, Mühling H, König U. Sheath pulling immediately after PTCA: Comparison of two different techniques for the hemostatic puncture closure device: A prospective, randomised study. Cathet Cardiovasc Diagn 1997;41:378-383.
16. Bertrand ME, Legrand V, Boland J, Fleck E, Bonnier J, Emmanuelson H, Vrolix M, Missault L, Chierchia S, Casaccia M, Niccoli L, Oto A, White C, Webb-Peploe M, van Belle E, McFadden EP. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: The FANTASTIC study. Circulation 1998;98:1597-1603.
17. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KKL, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE. A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting. N Engl J Med 1998;339:1665-1671.
18. Omuigui NA, Califf RM, Pieper K, Keeler G, O'Hanesian A, Berdan LG, Mark DB, Talley JD, Topol EJ. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-1). J Am Coll Cardiol 1995;26:922-930.
19. Blankenship JC, Hellkamp AS, Aguirre FV, Demko SL, Topol EJ, Califf RM, for the EPIC investigators. Vascular access site complications after percutaneous coronary interventions with abciximab in the evaluation of c7E3 for the prevention of ischemic complications (EPIC) trial. Am J Cardiol 1998;81:36-40.
20. Aguirre FV, Topol EJ, Ferguson JJ, Anderson K, Blankenship JC, Heuser RR, Sigmon K, Taylor M, Gottlieb R, Hanovich G, Rosenberg M, Donohoe TJ, Weisman HJ, Califf RM. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 1995;91:2882-2890.
21. Waksman R, King SB, Douglas JS, Shen Y, Ewing H, Mueller L, Ghazzal ZMB, Weintraub WA. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-889.
22. Heintzen MP, Strauer BE. Local vascular complications after cardiac catheterization. Herz 1998;23:4-20.
23. Henry M, Amor M, Allaoui M, Tricoche O. A new access site management tool: The Angio-Seal hemostatic puncture closure device. J Endovasc Surg 1995;2:289-296.
24. Silber S, Schön N, Seidel N, Heiß-Bogner J. Inadvertent occlusion of the common femoral artery following Angio-Seal deployment. Z Kardiol 1998;87:51-55.
25. Steinkamp HJ, Scheinert D, Hettwer M, Haufe P, Kenzel C, Biamino R, Felix R. PTLA recanalization of femoral artery stenosis/reocclusion after use of Angio-Seal. Fortschr Röntgenstr 1999;170:105-108.
26. Cremonesi A, Castriota F, Tarantino F, Troiani E, Ricci E, El Jamal B, Grattoni C, Noera G. Femoral arterial hemostasis using the Angio-Seal system after coronary and vascular percutaneous angioplasty and stenting. J Invas Cardiol 1998;10:464-469.
27. Gonze MD, Sternbergh WC, Salartash K, Money SR. Complications associated with percutaneous closure devices. Am J Surg 1999;178:209-211.
28. Lübkemann H, Haude M, Görge G, Baumgart D, Ge J, Dagres N, Sack S, Welge D, Mahr P, Erbel R. Immediate closure of femoral artery puncture site after cardiac catheterization by a new collagen: Anchor device (Angio-Seal) - Results in 1818 consecutive patients. Am J Cardiol 1997;80:255.
29. Meyners W, Fassbender D, Danch E, Breymann T, Gleichmann U. Critical stenoses and occlusions of the femoral artery after use of Angio-Seal after cardiac catheteization and coronary angioplasty. Z Kardiol 1999;88(Suppl I):27.
30. Eidt JF, Saucedo J, Moursi M, Webb J, Talley JD. Surgical complications from hemostatic puncture closure devices. Am J Cardiol 1999;84:143.
31. O'Sullivan GJ, Buckenham TM, Belli AM. The use of the Angio-Seal hemostatic puncture closure device in high risk patients. Clin Radiol 1999;54:51-55.
32. Tomlinson MA, Beese R, Banwell M, Loosemore T, Buckenham TM, Dormandy JA. Sequential retroperitoneal venous hemorrhage and embolism of an angio-seal puncture closure device complicating lilac artery angioplasty. J Endovasc Surg 1999;6:264-269.
33. Eggebrecht H, Haude M, Baumgart D, Erbel R. Infectious complications related to the use of the Angio-Seal hemostatic puncture closure device. Cathet Cardiovasc Intervent 2000;49:352-353.
34. Cooper CL, Miller A. Infectious complications related to the use of the Angio-Seal hemostatic puncture closure device. Cathet Cardiovasc Intervent 1999;48:301-303.
35. Seidelin PH, Adelman AG. Mobilization within thirty minutes of elective diagnostic coronary angiography: A feasibility study using a hemostatic femoral puncture closure device. J Intervent Cardiol 1997;10:409-415.
36. Muller DWM, Shamir KF, Ellis SG, et al. Peripheral vascular complications after conventional and complex percutaneous interventional procedures. Am J Cardiol 1992;69:63-68.
37. Kern MJ, Cohen M, Talley JD, et al. Early ambulation after 5 F diagnostic cardiac catheterization: Results of a multicenter trial. J Am Coll Cardiol 1990;15:1475-1483.
38. Klinke NP, Kubac G, Talibi T, et al. Safety of outpatient cardiac catheterization. Am J Cardiol 1985;56:639-641.
39. Ernst SMPG, Tjonjoegin RM, Schraeder R, Kaltenbach M, Sigwart U, Sanborn TA, Plokker HWT. Immediate sealing of arterial puncture sites after cardiac catheterization and coronary angioplasty using a biodegradable collagen plug: Results of an international registry. J Am Coll Cardiol 1993;21:851-855.
40. Silber S. 10 Years of vascular closure devices: A critical analysis of their usefulness after PTCA. Z Kardiol 2000;89:383-389.
41. Morice MC, Dumas P, Lefevre T, Loubeyre C, Louvard Y, Piechaud JF. Systematic use of transradial approach or suture of the femoral artery after angioplasty: Attempt at achieving zero access site complications. Cathet Cardiovasc Intervent 2000;51:417-421.
42. Kazmouz G, Ali A, LaLaonde T, Epp R, Michael J, Schreiber T. The safety of routine use of a femoral artery implantable device (Angio-Seal) after coronary angioplasty and stenting. Am J Cardiol 1999;84:141.
43. Kussmaul WG, Buchbinder M, Whitlow P, Aker UT, Heuser RR, King SB, Kent KM, Leon MB, Kolansky DM, Sandza JG. Femoral artery hemostasis using an implantable device (Angio-Seal) after coronary angioplasty. Cathet Cardiovasc Diagn 1996;37:362-365.
44. Murray CR, Mortazavi A, Warth DC, Buchbinder M. A randomized controlled prospective study of the Angio-Seal device versus manual pressure for rapid arterial puncture closure. Circulation 1996;94(Suppl I):2192.
45. Rodes J, Côté G, Bilodeau L, Doucet S, Tanguay JF, Bertrand OF, Bourassa MG, Perrault J. Early ambulation after percutaneous transluminal coronary angioplasty: A prospective randomized trial comparing manual compression and the 8F Angio-Seal hemostatic device. Am J Cardiol 1997;80:43.
46. Szto GYF, Rothbaum DA, Wong SC, Krukoff M, Knopf W, Casale P, Jenkins S, for the Angio-Seal Stent Early Ambulation Trial Investigators. Early ambulation after coronary stenting: Prospective randomized trial of Angio-Seal hemostatic puncture closure device versus manual compression: Interim analysis. Am J Cardiol 1997;80:252.